Apatinib is effective for treatment of advanced hepatocellular carcinoma.
about
A new apatinib microcrystal formulation enhances the effect of radiofrequency ablation treatment on hepatocellular carcinoma.Efficacy and safety of sorafenib versus apatinib in the treatment of intermediate and advanced hepatocellular carcinoma: a comparative retrospective study.Novel ADAM-17 inhibitor ZLDI-8 enhances the in vitro and in vivo chemotherapeutic effects of Sorafenib on hepatocellular carcinoma cells.Apatinib for patients with advanced or recurrent cervical cancer: study protocol for an open-label randomized controlled trialMolecular Targets in Hepatocarcinogenesis and Implications for Therapy
P2860
Apatinib is effective for treatment of advanced hepatocellular carcinoma.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Apatinib is effective for treatment of advanced hepatocellular carcinoma.
@en
Apatinib is effective for treatment of advanced hepatocellular carcinoma.
@nl
type
label
Apatinib is effective for treatment of advanced hepatocellular carcinoma.
@en
Apatinib is effective for treatment of advanced hepatocellular carcinoma.
@nl
prefLabel
Apatinib is effective for treatment of advanced hepatocellular carcinoma.
@en
Apatinib is effective for treatment of advanced hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Apatinib is effective for treatment of advanced hepatocellular carcinoma.
@en
P2093
Lunxiu Qin
Tianqiang Song
Xiaolin Zhu
Yinlong Kong
Yongqiang Zhang
P2860
P304
105596-105605
P356
10.18632/ONCOTARGET.22337
P407
P577
2017-11-06T00:00:00Z